Pharmacogenetic Testing

Pharmacogenetic
(PGx) Testing

Turn genetic data into actionable treatment insights that can help you narrow down medication choices and personalize dosing.
Get Started
2-part pill with DNA strand in top half with circled person gold

Genetic information should be essential when prescribing

Gain a better understanding of the patient’s unique genetic profile to reduce the painful process of trial and error and interaction risk.

270

medications contain FDA warnings, dosage recommendations or drug-drug interaction guidance based on specific gene variants.9

95%

of Genomind clinicians report they can now make safer, more informed treatment decisions with a higher level of confidence.10
Pharmacogenomics can play an important role in identifying responders and non-responders to medications, avoiding adverse events, and optimizing drug dose.

- Food and Drug Administration

Personalize medication plans with ease

We make it easy for you and your patient to access these critical treatment insights without compromising accuracy or depth of information.

Access comprehensive genetic insights with 24 genes to assess over 700 medications

Enjoy fast, easy and accurate processing. Painless cheek swab collection and results in 3-5 days or less with a 99.9% laboratory accuracy

Seamlessly incorporate into your care model with flexible collection options. Keep test kits on hand or send directly to patients. 

Offer payment options that work for your patients – HSA/FSA eligible, flexible payment plans, and financial assistance

How it works

Ordering, tracking, and status updates related to your testing results can be easily accessed by logging on to our Precision Health Platform after you register with Genomind.

Customized report views to fit your approach to treatment

Assess patient results based on your needs and approach with our flexible report views.
Genomind® Pharmacogenetic Sample Report (24 Genes)
View Sample Report

Pharmacodynamic
Gene Variation Report

Assess 15 pharmacodynamic (PD) gene results to understand how their genotype may affect tolerability and/or likelihood of responding to specific therapeutic options.

Genomind® sample pharmacogenetic test screengrab I. Pharmacodynamic Gene Variations
Genomind® sample pharmacogenetic test screengrab III. Pharmacokinetic Gene Variations

Pharmacokinetic
Gene Variation Report

Evaluate 9 pharmacokinetic (PK) gene results to understand how their genotype may affect drug metabolism and absorption of certain drugs.

Gene-Drug Interaction
Summary Report

Understand how your patient’s genetic profile interacts with commonly prescribed medications synthesizing both the PK and PD results for each drug. Understand how their genotype may influence biological response, drug absorption, metabolism, or blood-brain barrier penetration.

Genomind® sample pharmacogenetic test screengrab III. Gene-Drug Interaction Summary
Genomind® sample pharmacogenetic test screengrab IV. Depression Summary

Diagnosis-Specific
Summary Report

All results are organized into one visually plotted view based on clinical diagnosis. When you’re running short on time – this may be the report view for you!

Test Methodology /
Literature Reference

Easily access descriptions of test methodology, more detailed information regarding the genetic variants tests (i.e. single-nucleotide polymorphisms), and literature references.
Screengrab of Test Methodology / Literature Reference
Genomind® sample Patient Drug Metabolism Card

Patient Drug Metabolism Card

Knowing the way your patient metabolizes medication is as important as knowing their blood type. Extend the value of your patient’s genetic report. Patients can share their individual genotype, for six gene variations that impact drug metabolism, with any provider.

Built on the most up-to-date clinical evidence

As science evolves, so do we. Learn about the evidence the report was built on and our commitment to staying current.
Learn More

PGx is the future of medicine. I use it to bring precision to my prescribing. Now, I can more accurately predict adverse drug events, even outside of my specialty. This process builds better relationships with patients and other providers.

Jennifer Reed, FNP-BC, PMHNP-BC

Private Practice Owner, Board Certified in Family Practice and Psychiatric Mental Health

Access critical treatment insights today.

Get Started